Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Intrepid Potash
IPI
$503M
| $2.35M | ﹤0.01% |
19,693
-11,835
| -38% | -$1.4M |
|
|
NBG
1802
DELISTED
NATIONAL BANK OF GREECE SA ADR REPSTG 1 SHARE (NEW)
NBG
| $2.35M | ﹤0.01% |
+2,237,774
| New | +$2.89M |
|
|
SRNE
1803
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $2.35M | ﹤0.01% |
133,270
-339,414
| -72% | -$4.36M |
|
|
DCM
1804
DELISTED
NTT DOCOMO, Inc.
DCM
| $2.34M | ﹤0.01% |
122,344
-30,497
| -20% | -$561K |
|
|
YDLE
1805
DELISTED
YODLEE INC COMMON STOCK
YDLE
| $2.34M | ﹤0.01% |
161,930
+79,401
| +96% | +$1.1M |
|
1806
Flex
FLEX
$41.3B
| $2.34M | ﹤0.01% |
274,102
-376,076
| -58% | -$3.46M |
|
1807
Maximus
MMS
$3.09B
| $2.33M | ﹤0.01% |
+35,425
| New | +$2.32M |
|
1808
CALL
Sunoco
SUN
$14.1B
| $2.33M | ﹤0.01% |
51,400
+46,000
| +852% | +$2.21M |
|
|
ALJ
1809
DELISTED
Alon USA Energy Inc
ALJ
| $2.33M | ﹤0.01% |
123,018
-1,149,808
| -90% | -$19.6M |
|
1810
OFG Bancorp
OFG
$2.21B
| $2.32M | ﹤0.01% |
217,840
+101,547
| +87% | +$1.46M |
|
1811
OraSure Technologies
OSUR
$256M
| $2.32M | ﹤0.01% |
430,334
-2,061,645
| -83% | -$12.7M |
|
|
AVID
1812
DELISTED
Avid Technology Inc
AVID
| $2.32M | ﹤0.01% |
173,603
+38,321
| +28% | +$612K |
|
1813
Dr. Reddy's Laboratories
RDY
$10.2B
| $2.31M | ﹤0.01% |
209,150
+116,095
| +125% | +$1.28M |
|
1814
Renasant Corp
RNST
$3.75B
| $2.31M | ﹤0.01% |
70,993
-90,425
| -56% | -$2.76M |
|
1815
Deutsche Bank
DB
$75.6B
| $2.31M | ﹤0.01% |
+85,727
| New | +$2.49M |
|
|
SPTN
1816
DELISTED
SpartanNash
SPTN
| $2.31M | ﹤0.01% |
70,958
+9,927
| +16% | +$317K |
|
|
TSS
1817
DELISTED
Total System Services, Inc.
TSS
| $2.31M | ﹤0.01% |
55,287
+6,032
| +12% | +$244K |
|
|
MXIM
1818
DELISTED
Maxim Integrated Products
MXIM
| $2.31M | ﹤0.01% |
66,683
-521,894
| -89% | -$17.8M |
|
|
STR
1819
DELISTED
QUESTAR CORP
STR
| $2.3M | ﹤0.01% |
110,109
+42,309
| +62% | +$963K |
|
1820
Ball Corp
BALL
$17B
| $2.3M | ﹤0.01% |
65,600
-822,288
| -93% | -$29.7M |
|
|
MSCC
1821
DELISTED
Microsemi Corp
MSCC
| $2.3M | ﹤0.01% |
65,802
-171,807
| -72% | -$6.03M |
|
1822
Extreme Networks
EXTR
$2.98B
| $2.3M | ﹤0.01% |
854,800
+289,050
| +51% | +$780K |
|
|
EXXI
1823
PUT
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $2.3M | ﹤0.01% |
873,800
| – | – |
|
|
S
1824
CALL
DELISTED
Sprint Corporation
S
| $2.28M | ﹤0.01% |
+500,000
| New | +$2.41M |
|
|
XLRN
1825
DELISTED
Acceleron Pharma
XLRN
| $2.27M | ﹤0.01% |
+71,865
| New | +$2.32M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.